Abstract Purpose of Review Current guidelines for the management of arterial hypertension
endorse β-adrenergic receptor blocking agents (beta-blockers, BBs) as being particularly …

National and international guidelines still recommend β-blockers (BBs) as first-line agents in
uncomplicated prevention of hypertension. However, it has been shown that BBs reduce …

Theoretical considerations and results from experimental studies in animal models suggest
that long-term β-adrenergic blockade should be antiatherogenic. Some of these …

Beta Receptor Blocking Agents in the Secondary Prevention of Coronary Heart Disease
Page 1 Ann. Rev. Pharmacol. TOJCicoL 1983. Z3:Z9-44 Copyright @ 1983 by Annual …

β-Blockers are used commonly worldwide in clinical practice for lowering blood pressure.
Most of the agents in this class are efficacious in reducing blood pressure, although they …

Importance of the field: It is important to know which patients with hypertension will benefit
from beta-blocker therapy and which beta-blockers should be used in the treatment of …

The concept of two patterns of catecholamine activity was first described at the turn of the
century by Langely and Dale. In the late 1940s, Ahlquist conceptualized the alpha-and beta …

In the past 4 decades, β blockers (BBs) have been widely used in the treatment of
uncomplicated hypertension and are still recommended as first-line agents in national and …

Epidemiologic and experimental data are reviewed to determine whether treatment with
beta-adrenergic blocking agents ('beta blockers') is likely to be antiatherogenic. Both indirect …

Some national guidelines on hypertension have demoted beta-blockers from a first-choice to
a fourth-choice treatment. In contrast, the 2007 guidelines of the European Society of …